The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Artificial Blood Products-Global Market Insights and Sales Trends 2024
Synopsis
The global Artificial Blood Products market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Artificial Blood Products in various end use industries. The expanding demands from the Military and Civil, are propelling Artificial Blood Products market. Perfluorocarbon-based Oxygen Carrier (PFBOC), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Hemoglobin-based Oxygen Carrier (HBOC) segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Artificial Blood Products, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Artificial Blood Products market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Artificial Blood Products market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Artificial Blood Products sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Artificial Blood Products covered in this report include Aurum Biosciences Ltd., HEMARINA SA, HbO2 Therapeutics, KaloCyte Inc., SpheriTech Ltd. and NuvOx Pharma, etc.
The global Artificial Blood Products market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Aurum Biosciences Ltd.
HEMARINA SA
HbO2 Therapeutics
KaloCyte Inc.
SpheriTech Ltd.
NuvOx Pharma
Global Artificial Blood Products market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Artificial Blood Products market, Segment by Type:
Perfluorocarbon-based Oxygen Carrier (PFBOC)
Hemoglobin-based Oxygen Carrier (HBOC)
Global Artificial Blood Products market, by Application
Military
Civil
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Artificial Blood Products manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Artificial Blood Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Artificial Blood Products market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Artificial Blood Products in various end use industries. The expanding demands from the Military and Civil, are propelling Artificial Blood Products market. Perfluorocarbon-based Oxygen Carrier (PFBOC), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Hemoglobin-based Oxygen Carrier (HBOC) segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Artificial Blood Products, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Artificial Blood Products market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Artificial Blood Products market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Artificial Blood Products sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Artificial Blood Products covered in this report include Aurum Biosciences Ltd., HEMARINA SA, HbO2 Therapeutics, KaloCyte Inc., SpheriTech Ltd. and NuvOx Pharma, etc.
The global Artificial Blood Products market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Aurum Biosciences Ltd.
HEMARINA SA
HbO2 Therapeutics
KaloCyte Inc.
SpheriTech Ltd.
NuvOx Pharma
Global Artificial Blood Products market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Artificial Blood Products market, Segment by Type:
Perfluorocarbon-based Oxygen Carrier (PFBOC)
Hemoglobin-based Oxygen Carrier (HBOC)
Global Artificial Blood Products market, by Application
Military
Civil
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Artificial Blood Products manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Artificial Blood Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Artificial Blood Products Market Overview
1.1 Artificial Blood Products Product Overview
1.2 Artificial Blood Products Market Segment by Type
1.2.1 Perfluorocarbon-based Oxygen Carrier (PFBOC)
1.2.2 Hemoglobin-based Oxygen Carrier (HBOC)
1.3 Global Artificial Blood Products Market Size by Type
1.3.1 Global Artificial Blood Products Market Size Overview by Type (2018-2029)
1.3.2 Global Artificial Blood Products Historic Market Size Review by Type (2018-2023)
1.3.3 Global Artificial Blood Products Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Artificial Blood Products Sales Breakdown by Type (2018-2023)
1.4.2 Europe Artificial Blood Products Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Artificial Blood Products Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Artificial Blood Products Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Artificial Blood Products Sales Breakdown by Type (2018-2023)
2 Global Artificial Blood Products Market Competition by Company
2.1 Global Top Players by Artificial Blood Products Sales (2018-2023)
2.2 Global Top Players by Artificial Blood Products Revenue (2018-2023)
2.3 Global Top Players by Artificial Blood Products Price (2018-2023)
2.4 Global Top Manufacturers Artificial Blood Products Manufacturing Base Distribution, Sales Area, Product Type
2.5 Artificial Blood Products Market Competitive Situation and Trends
2.5.1 Artificial Blood Products Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Artificial Blood Products Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Artificial Blood Products as of 2022)
2.7 Date of Key Manufacturers Enter into Artificial Blood Products Market
2.8 Key Manufacturers Artificial Blood Products Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Artificial Blood Products Status and Outlook by Region
3.1 Global Artificial Blood Products Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Artificial Blood Products Historic Market Size by Region
3.2.1 Global Artificial Blood Products Sales in Volume by Region (2018-2023)
3.2.2 Global Artificial Blood Products Sales in Value by Region (2018-2023)
3.2.3 Global Artificial Blood Products Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Artificial Blood Products Forecasted Market Size by Region
3.3.1 Global Artificial Blood Products Sales in Volume by Region (2024-2029)
3.3.2 Global Artificial Blood Products Sales in Value by Region (2024-2029)
3.3.3 Global Artificial Blood Products Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Artificial Blood Products by Application
4.1 Artificial Blood Products Market Segment by Application
4.1.1 Military
4.1.2 Civil
4.2 Global Artificial Blood Products Market Size by Application
4.2.1 Global Artificial Blood Products Market Size Overview by Application (2018-2029)
4.2.2 Global Artificial Blood Products Historic Market Size Review by Application (2018-2023)
4.2.3 Global Artificial Blood Products Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Artificial Blood Products Sales Breakdown by Application (2018-2023)
4.3.2 Europe Artificial Blood Products Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Artificial Blood Products Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Artificial Blood Products Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Artificial Blood Products Sales Breakdown by Application (2018-2023)
5 North America Artificial Blood Products by Country
5.1 North America Artificial Blood Products Historic Market Size by Country
5.1.1 North America Artificial Blood Products Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Artificial Blood Products Sales in Volume by Country (2018-2023)
5.1.3 North America Artificial Blood Products Sales in Value by Country (2018-2023)
5.2 North America Artificial Blood Products Forecasted Market Size by Country
5.2.1 North America Artificial Blood Products Sales in Volume by Country (2024-2029)
5.2.2 North America Artificial Blood Products Sales in Value by Country (2024-2029)
6 Europe Artificial Blood Products by Country
6.1 Europe Artificial Blood Products Historic Market Size by Country
6.1.1 Europe Artificial Blood Products Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Artificial Blood Products Sales in Volume by Country (2018-2023)
6.1.3 Europe Artificial Blood Products Sales in Value by Country (2018-2023)
6.2 Europe Artificial Blood Products Forecasted Market Size by Country
6.2.1 Europe Artificial Blood Products Sales in Volume by Country (2024-2029)
6.2.2 Europe Artificial Blood Products Sales in Value by Country (2024-2029)
7 Asia-Pacific Artificial Blood Products by Region
7.1 Asia-Pacific Artificial Blood Products Historic Market Size by Region
7.1.1 Asia-Pacific Artificial Blood Products Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Artificial Blood Products Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Artificial Blood Products Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Artificial Blood Products Forecasted Market Size by Region
7.2.1 Asia-Pacific Artificial Blood Products Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Artificial Blood Products Sales in Value by Region (2024-2029)
8 Latin America Artificial Blood Products by Country
8.1 Latin America Artificial Blood Products Historic Market Size by Country
8.1.1 Latin America Artificial Blood Products Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Artificial Blood Products Sales in Volume by Country (2018-2023)
8.1.3 Latin America Artificial Blood Products Sales in Value by Country (2018-2023)
8.2 Latin America Artificial Blood Products Forecasted Market Size by Country
8.2.1 Latin America Artificial Blood Products Sales in Volume by Country (2024-2029)
8.2.2 Latin America Artificial Blood Products Sales in Value by Country (2024-2029)
9 Middle East and Africa Artificial Blood Products by Country
9.1 Middle East and Africa Artificial Blood Products Historic Market Size by Country
9.1.1 Middle East and Africa Artificial Blood Products Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Artificial Blood Products Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Artificial Blood Products Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Artificial Blood Products Forecasted Market Size by Country
9.2.1 Middle East and Africa Artificial Blood Products Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Artificial Blood Products Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Aurum Biosciences Ltd.
10.1.1 Aurum Biosciences Ltd. Company Information
10.1.2 Aurum Biosciences Ltd. Introduction and Business Overview
10.1.3 Aurum Biosciences Ltd. Artificial Blood Products Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Aurum Biosciences Ltd. Artificial Blood Products Products Offered
10.1.5 Aurum Biosciences Ltd. Recent Development
10.2 HEMARINA SA
10.2.1 HEMARINA SA Company Information
10.2.2 HEMARINA SA Introduction and Business Overview
10.2.3 HEMARINA SA Artificial Blood Products Sales, Revenue and Gross Margin (2018-2023)
10.2.4 HEMARINA SA Artificial Blood Products Products Offered
10.2.5 HEMARINA SA Recent Development
10.3 HbO2 Therapeutics
10.3.1 HbO2 Therapeutics Company Information
10.3.2 HbO2 Therapeutics Introduction and Business Overview
10.3.3 HbO2 Therapeutics Artificial Blood Products Sales, Revenue and Gross Margin (2018-2023)
10.3.4 HbO2 Therapeutics Artificial Blood Products Products Offered
10.3.5 HbO2 Therapeutics Recent Development
10.4 KaloCyte Inc.
10.4.1 KaloCyte Inc. Company Information
10.4.2 KaloCyte Inc. Introduction and Business Overview
10.4.3 KaloCyte Inc. Artificial Blood Products Sales, Revenue and Gross Margin (2018-2023)
10.4.4 KaloCyte Inc. Artificial Blood Products Products Offered
10.4.5 KaloCyte Inc. Recent Development
10.5 SpheriTech Ltd.
10.5.1 SpheriTech Ltd. Company Information
10.5.2 SpheriTech Ltd. Introduction and Business Overview
10.5.3 SpheriTech Ltd. Artificial Blood Products Sales, Revenue and Gross Margin (2018-2023)
10.5.4 SpheriTech Ltd. Artificial Blood Products Products Offered
10.5.5 SpheriTech Ltd. Recent Development
10.6 NuvOx Pharma
10.6.1 NuvOx Pharma Company Information
10.6.2 NuvOx Pharma Introduction and Business Overview
10.6.3 NuvOx Pharma Artificial Blood Products Sales, Revenue and Gross Margin (2018-2023)
10.6.4 NuvOx Pharma Artificial Blood Products Products Offered
10.6.5 NuvOx Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Artificial Blood Products Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Artificial Blood Products Industrial Chain Analysis
11.4 Artificial Blood Products Market Dynamics
11.4.1 Artificial Blood Products Industry Trends
11.4.2 Artificial Blood Products Market Drivers
11.4.3 Artificial Blood Products Market Challenges
11.4.4 Artificial Blood Products Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Artificial Blood Products Distributors
12.3 Artificial Blood Products Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
